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Received 4 September 2007; received in revised form 11 December 2007; accepted 19 December 2007; Available online 5 February 2008AbstractIntroduction: Latest techniques enable positioning of devices into the coronary sinus (CS) for mitral valve (MV) annuloplasty. We evaluate the
feasibility of non-invasive assessment to determine CS anatomy and its relation to MV annulus and coronary arteries by multi-slice CT (MSCT) in
normal and insufficient MV. Methods: Fifty patients (33 males, 17 females, age 67  11 years) were studied retrospectively by 64-MSCTscans for
anatomical criteria regarding CS and its relation to MVannulus and circumflex artery (CX).We included 24 patients with severemitral insufficiency
and 26 with no MV disease. Diameter of MV, of proximal and distal ostium of CS, length and volume of CS, angle between anterior interventricular
vein (AIV) and CS, caliber change of CX before, under/over and after CS were analysed. Different anatomical correlations were demonstrated:
distance of MVannulus to CS, CX to CS. Results: Diameter of proximal CS ostium was significantly larger in insufficient MV compared to normal MV
(11  2.8 mm vs 9.9  2.5 mm; p < 0.024). CS was significantly longer in patients with insufficient MV (125.4  17 mm vs 108.9  18 mm;
p < 0.003) with also significant differences in volume of CS (p < 0.039). Significant difference in annulus diameter, 46.1  6 mm (insufficient MV)
versus 39.5  7.5 mm, p < 0.004 was observed. Angle CS—AIV was 103.5  298 (range 528—1448) in insufficient valves versus 118.2  24.58 (range
738—1668) in normal valves with a tendency to higher angles in normal valves ( p = 0.06). Distance of MV annulus to CS measured 16  4.1/
14.2  3.6 mm (insufficient/normal MV) without significant difference between groups. In 15 patients CX ran under CS. Eighty-four percent of
these patients (13/15) show a decrease in CS caliber in the area of intersection. In 14 patients CS ran over and in one patient the diameter of the
CS at intersecting region was smaller. In 16 patients no direct point of contact was visible, in five patients CX to CS positioning was not evaluable.
Conclusion: There is a significant anatomic difference between normal and insufficient MV, which might be the basis for any interventional
approaches through the CS. Exact measurements of all structures and its anatomic correlations are possible with MSCT, which allows pre-
interventional planning.
# 2007 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.
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Minimally invasive techniques for treatment of cardiac
diseases are increasingly being adopted by cardiovascular
surgeons and used in their clinical routine [1—5]. Innovative
techniques, which were continuously developed and mod-
ified, enable procedures, which not only open complete new
therapeutic options but also require new surgical skills.
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doi:10.1016/j.ejcts.2007.12.041insufficiency (MVI) in the form of an implantation of a
coronary sinus (CS) annuloplasty device represents one of
these new emerging techniques [6—10].
In general the less visible the region of interest is, the
more important is the knowledge of the anatomy and an
accurate preoperative planning. In previous studies the
electron beam computertomography (CT) and multi-slice
computertomography (MSCT) were already described as a
valid imaging tool for cardiac diagnostic and illustration of
the anatomy and topography of the heart including the
venous system. In addition it enables preoperative planning
with a measurement of the coronary venous system including
the CS and its adjacent structures [11—15].
MSCT imaging of the CS has also been described as the
preferred method compared to a catheter-based direct orSurgery. Published by Elsevier B.V. All rights reserved.
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always deliver sufficient information [16]. Furthermore, it is
less convenient for the patients and represents a small risk of
complications.
In this retrospective study we assessed the coronary
venous system including the CS and the surrounding
anatomical structures in patients with and without mitral
valve insufficiency by MSCT with regard to annuloplasty
device implantation into the coronary sinus..2. Methods
2.1. Patients
Fifty patients (33 males/17 females, age 67  11 years)
who underwent MSCTexaminations for preoperative planning
in minimally invasive valve surgery in clinical routine were
studied retrospectively. Twenty-four patients suffered with a
MVI, 26 patients had normal functional and non-pathological
MV.
2.2. Multi-slice computertomography and image
reconstruction
All scans were performed by a 64-MSCT (GE Healthcare,
Milwaukee, USA).
Patients with heart rates >65 bpm were pretreated with
5—10 mg intravenous Metoprolol (Lopresor, Sankyo Pharma
AG, Switzerland) and all patients received 2.5 mg sublingual
isosorbiddinitrate (Isoket, Schwarz Pharma, Monheim, Ger-
many) prior to the scan if no contraindications were present.
Patients with an allergy to iodinated contrast media, renal
insufficiency (serum creatinine > 140 mmol/l) were
excluded from the study.
Scanning parameters: detector collimation: 64 mm  0.625 mm
 gantry rotation time: 350 ms
 scan field of view: 25 cm
 tube voltage: 120 kV
 tFig. 1. (A) Measurement of the angle between CS and AIV; (B) length measure-
ment of the CS; (C) volume measurement of the CS.ube current: 200 mA
A bolus of 70—100 ml of non-ionic contrast agent
(UltravistW 370 mg/ml, Schering AG, Germany) was con-
tinuously injected intravenously (50—80 ml at 5.0 ml/s, then
20 ml at 3.5 ml/s) followed by a saline chaser bolus of 50 ml
at a flow rate of 3.5 ml/s. CT scan was automatically started
when the signal attenuation reached the predefined thresh-
old of 100 Hounsfield units (HU) in the aorta (bolus tracking).
2.3. MSCT image analysis and evaluation protocol
After image acquisition the complete image data set was
transferred to a designated workstation (Advantage Work-
station 4.3, GE Healthcare) and was analysed using the
CardIQ Express software (GE Healthcare). Image interpreta-
tion was performed from axial-source images, multi-planar
reformations, and three-dimensional (3D) volume renderings
in 75% phase (end-diastole) and with the program ‘Tree
Volume Rendering ’.2.3.1. Mitral valve characteristics
The mitral valve annulus (MVA) was sized in diameter in a
three-chamber view. diameter of MV (mm)
2.3.2. Coronary sinus characteristics
The coronary sinus characteristics were measured in 3D
volume rendering technique (VRT) and axial 2D view. angle between CS and anterior interventricular vein (AIV)
(3D VRT) (Fig. 1A) length (3D VRT) (Fig. 1B)
 volume (3D VRT) (Fig. 1C)
 diameter of proximal ostium (axial 2D-view)
 diameter of distal ostium (axial 2D-view)
 caliber changes (3D VRT)
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Table 1
Patient characteristics
Normal MV MVI
Age (years), mean  SD 68  11 65  11
Gender, male/female 16/10 17/72.3.3. Relationship between coronary sinus and mitral
valve annulus
The position of the CS to the MVAwas evaluated in 3D VRT
of the heart. The distance measurements were performed in
axial 2D viewEF (%) 58  9 56  8
Diabetes mellitus 2 0 CTab
Me
Pa
Mi
Co
Re
SigS parallel (above/same level)/oblique to MVA
Hypercholesterolemia 9 6 d
Hypertension 14 11
Smoking 13 6
Obesity (patients) 5 2
Body mass index (kg/m2) 25.5  3 24.7  3.9
Length (cm) 167  10 172  11
Weight (kg) 72  12 73  15istance between MVA and CS: the distance was directly
measured from the middle part of the CS to the MVA in the
shortest way.
2.3.4. Relationship between coronary sinus and
circumflex artery (CX)
Assessment of any significant change of the diameter of
the CX before compared to after intersection with the CS
between a CS over- and undercrossing CX. positioning of CX to the CS: beneath/above/parallel
 distance CS to CX in parallel run
 diameter of the CX before, in and after intersection
2.4. Statistical analysis
Quantitative variables were expressed as mean  stan-
standard deviation and categorical variables as frequencies
or percentages. Statistical analyses were performed with
Student’s t-test, p-value of <0.05 was considered as
statistically significant.3. Results
In total, 50 patients (age 67  11; 33 male/17 female)
were included in this study in which the coronary venous
system could be accurately visualized, only in five patients
could the relationship between the CS and the CX not be
illustrated. Twenty-six individuals with normal MV function
and 24 with MVI were studied. The proportion of left/right
and intermediate coronary dominance was classified in 74%
(37/50) right, 6% (3/50) left and 20% (10/50) intermediate
coronary dominance. Detailed patient characteristics are
listed in Table 1.
All patients of this study sufferedwith valve disease. The 26
patients with a normalmitral valve had an aortic valve disease
(23 patients aortic stenosis, three combined aortic valve
disease). Of the patients with mitral valve insufficiency twole 2
asurement parameters of mitral valve (MV) and coronary sinus (CS)
rameters Normal mitral valve
tral valve characteristics
Annulus diameter (mm) 39.5  7.5
ronary sinus characteristics
Diameter proximal ostium (mm) 9.9  2.5
Diameter distal ostium (mm) 4.2  1
Length of CS (mm) 108.9  18
Volume of CS (%) 17.1  4.3
Angle CS—AIV (8) 118.5  24.5
lation coronary sinus and mitral valve annulus
Distance (mm) 14.2  3.6
nificant differences between normal and pathologic MV.patients had grade II, four patients grade III and 18 patients
grade IV. Twenty-two patients showed structural defects: 17
patients showedaposterior, threepatients ananterior and two
patients an anterior as well as posterior prolapse. In three
patients chordal ruptures could be illustrated. In one patient
MVI grade IV was concomitant with an endocarditis and in
another patient with a rheumatic disease.
In all patients isolated valve surgery was performed in
minimally invasive fashion via a 6 cm right lateral thor-
acotomy.
3.1. Mitral valve and coronary sinus: characteristics and
relationships
We evaluated different characteristics of the MV and CS
and could demonstrate a significant difference in almost all
of these values between normal MV compared to MVI. The
diameter of proximal CS ostium was significantly larger in
insufficient MV compared to normal MV (11  2.8 mm vs
9.9  2.5 mm; p < 0.024). CS was significantly longer in
patients with insufficient MV (125.4  17 mm vs
108.9  18 mm; p < 0.003) with also significant differences
in volume of CS ( p < 0.039). In addition a significant
difference in annulus diameter in insufficient MV compared
to normal valves was noticed (6.1  6 mm vs 39.5  7.5 mm,
p < 0.004). The angle CS—AIV was 103.5  298 (range 528—
1448) in insufficient valves versus 118.2  24.58 (range 738—
1668) in normal valves with a tendency to higher angles in
normal valves ( p = 0.06). Distance of MV annulus to CS
measured 16  4.1/14.2  3.6 mm (insufficient/normal MV)
without a significant difference between the groups
(Table 2).Mitral valve insufficiency Significance
46.1  7.6 0.004
11.0  2.8 0.024
4.5  0.7 0.37
125.4  17 0.003
20.7  7 0.039
103.5  29 0.060
16  4.1 0.69
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annulus, on the same level in 34% (17/50) and in 54% (27/50)
above the annulus. However, the CS ran oblique to the MV
annulus in 12% (6/50) (Fig. 2A/B).
In five patients the CS showed caliber changes from the
proximal to the distal part (Fig. 3).
There was no significant influence of the body mass index
(BMI) noticeable on any anatomical correlations.
3.2. Relationships between coronary sinus and
circumflex artery
We assessed the different relationships between CS and
CX (Table 3) whereas in five patients these measurements
were not evaluable.Fig. 2. (A) Parallel course of CS above the MVA (black arrow); (B) oblique
position of the CS to the MVA (black arrow).
Fig. 3. Caliber jump in the middle part of the CS (black arrow).
Table 3
Circumflex branch (CX) correlation to coronary sinus (CS)
CX—CS constellation CX above CS CX underneath CS
No. of patients 14 15
Ø CX before CS intersection (mm) 3.4  0.9 3.2  0.8
Ø CX in CS intersection (mm) 3.3  0.8 2.8  0.6
Ø CX after CS intersection (mm) 3.4  0.8 3.3  0.7In 33% of the patients (15/45) CX runs under the CS. Of
these patients 87% (13/15) show a decrease in caliber in the
area of the intersection (Fig. 4), 0.5  0.3 mm (range 0.4—
1.1 mm) difference before intersection to the intersection,
0.4  1 mm (range 0.2—0.7 mm) difference from intersec-
tion to after intersection. In 31% of patients (14/45) the CX
overcrosses the CS and only in 4% (1/14) the diameter was
smaller in intersection region. In 36% (16/45) there was no
point of direct or indirect contact of the CX and CS visible
because no point of intersection or of a parallel run was
present (Fig. 5). If both structures were parallel, the
distances were in mean 3.3  1 mm.4. Discussion
The CS is a cardiac structure, which was mainly the focus
of interventional electrophysiological approaches, such as
pacemaker lead placement for cardiac resynchronization
therapy or radiofrequency ablation [17,18].
Since the introduction of CS annuloplasty devices for
treatment of functional mitral valve insufficiency, the
spectrum of application tools that are being inserted into
CS, has been further increased [19,20]. Therefore, a detailed
A. Plass et al. / European Journal of Cardio-thoracic Surgery 33 (2008) 583—589 587
Fig. 4. CX underneath of the CS (black arrow).knowledge of the coronary venous system including the CS
regarding anatomy and size as well as the correlation to the
adjacent anatomic structures became increasingly important.
Echocardiography is the gold standard for functional valve
diagnostic and detailed description of potential valve
pathologies like chordal rupture; however, the illustration
of the valve morphology and circumfluent structures is
limited. Since the introduction of the MSCT in 1994, CT-Fig. 5. Parallel run of the CX to CS (white arrow).technology in the form of the latest models (64-MSCT, DSCT)
became a high quality cardiac imaging tool which enables the
illustration of heart structures in two- and three-dimensions.
MSCTscans enable an optimized preoperative planning for CS
device implantation and allows for postoperative follow-up.
This study demonstrates significant differences between
normal MV compared to MVI regarding length of the CS and
distances of the CS to adjacent structures. It is important to
notice that the characteristics of the evaluated mitral valve
insufficiencies are mostly of structural nature. Almost all
(22/24) insufficiencies in this study are caused by structural
changes like prolapse and/or chordal rupture, which could
lead to anatomic changes of the surrounding tissue of the
mitral valve. Although the changes of the heart in form of size
and structure and consequently of the CS caused by chronic
MVI are finally equally independent of the character of MVI
because the mechanism of volume overload in the left
ventricle is identical. These changes could be a reasonable
factor for the function of a device implantation into the
coronary sinus. Not only will the mitral valve annulus be
downsized, the CS itself could be shaped similar to the
original form. Especially the combination between CS
shaping and MVA downsizing could cause a successful
treatment of the mitral valve insufficiency due to non-
structural disorders, i.e. ischemia and annulus dilatation.
In case of structural disorders of the mitral valve more
interventional technical options for mitral valve repair like
the percutaneously inserted Alfieri Clip are being developed.
However, multiple studies are still needed to assess the
correct indications for each of these procedures individually
[21—23]. In future a combination of CS devices implantation
and Alfieri Clip placement might be an additional therapeutic
option for patients with structural mitral valve prolapse.
Our data now allows for a description of the anatomical
differences of the CS in normal mitral valves compared to
MVI, which can then be used for a possible correlation to
grade functional mitral valve insufficiency. In addition it
would also be interesting to see in a follow-up CT scan
possible changes of the different cardiac structures after
successful treatment of the MVI. If there were a regression of
size of the different structures this would also give additional
information of the effectiveness of the implanted device with
regard to the function of the mitral valve.
The correlation of the CS to the CX and the influence to
each other in form of a possible compression of the CX after
device implantation has already been described [6,8].
However, it has not yet been defined what exact position
of both structures to each other is leading to this
complication. Possible factors which promote coronary
artery compression are: force of the direct compression of
the CX after device implantation, distance between the CS
and CX and the position to each other, quality of the vessel
wall and the diameter of the CX. Also the diameter change in
the region of the intersection of the CX and CS can be an
influencing factor for possible compression of the CX after
implantation of a device into the CS. In our study the CX
overcrossed the CS in 31% of our patients, which is
comparable to the study of Tops et al. [13] (32%). However,
in our study only 33% clearly run under the CS compared to
68% in the study of Tops et al. In their study a run of the CX
under the CS automatically meant an increased risk for any
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reasons. We found in our study that in 87% (13/15 patients)
the diameter of the CX was smaller at the point of the
intersection if the CX is underneath the CS compared to the
parts before and after intersection. This could represent an
increased risk for compression of the artery after device
implantation. However, the CX did cross over the CS in one
patient and showed a decreased diameter in the intersection
with the CS. Therefore, we believe that an overcrossing CX
does not necessarily mean that it would be safe to implant a
device into the CS.
In a situation where the diameter of the CX is decreased a
relevant compression after device implantation seems likely.
In all other patients without any caliber changes, which
represent 58% of the population, a device implantation is
theoretically possible. Whether it would be fully efficient,
however, is unclear.
Relevant for the effectiveness of the device besides the
distance between CS and MVA is also the positioning of both
structures to each other. Maselli at al. [8] demonstrated in
their anatomic study that the CS does not run in the proximity
of the MA but mainly on the back-wall of the left atrium
superior to the MA. This anatomic finding can only be partly
confirmed in our study. In 54% of the patients the CSwas above
the MVA, in 34% the CS was on the same level as the MVA.
However, we believe that not only the distance in vertical
direction of both structures might be important but also the
positioning to each other, if parallel or oblique (Fig. 2A/B). In
cases of an oblique constellation between CS and MA an
inferior efficacy of the implanted device might be the
consequence. In our study in 88% of the patients the CS was
parallel (above and same level) and in 12% oblique to the MV
annulus.
In addition the distance between CS and MVA may play a
role for the device efficiency. Our measurements from the
middle part of the CS to the MVA showed a longer distance in
the patients with insufficient valves (16  4.1 mm) but with
no significant difference compared to normal valves
(14.2  3.6 mm). Tops et al. [13] measured shorter distances
between CS and MVA (4.8—7.3 mm) and also a significant
difference between normal and insufficient valves.
Another problem for the CX could occur in form of a
possible zigzag of the vessels caused by the device, which can
lead to relevant impairment of blood supply to the
myocardium.
The mechanism of the CS annuloplasty device is
comprehensible but the degree of shrinkage and the force
generated by the device has not been completely under-
stood. This mechanism is dependent on many factors, which
are individual to the anatomical situation and the position of
the device. A few possible relevant factors are described and
evaluated in this study. But also the specific morphology of
the CS can influence the effectiveness of the device. The
MSCT examination was primarily performed for imaging the
coronary arteries, however, the illustration of the complete
venous system with this protocol was suboptimal. Also when
the CS, great vein and AIV were clearly visible in all
examinations, the small venous branches of the CS could not
be visualized completely. We believe, that these side
branches on the convex side of the CS could decrease the
elasticity of the surrounding tissue, which attenuates thebending character of the device. If this really is the case it
needs to be further evaluated.
From these data we estimate that 42% (19/45) of all
evaluablepatientswouldprobablynotbeperfectly suitable for
a CS device implantation: two patients with anomalies in the
CS (parallel to theannulus)withnocaliber changeof theCX, 14
patients with decreased diameter of the CX in the intersection
with the CS (in two patients combinedwith CS anomaly) and in
threepatientswithanobliquepositionof thenormal shapedCS
to the annulus with no caliber change of the CX.
A final conclusion of the efficacy can only be done after
implantation in a clinical trial with short and long-term
follow-up. In order to achieve optimal results in the future
these devices should be modified to the individual patient
according to the preoperative CT measurements.
The validationof theCSmeasurements byMSCTwas already
reported by Muehlenbruch et al. [16] who compared the CT
measurements in a 4-slice CT-scanner with conventional
angiography. The technical development to 64-slice CT
scanners offers higher spatial and temporal resolutions and
certainly enables an improved illustration of the venous
system.
5. Conclusion
In this study we can confirm that MSCT allows exact
depiction and measurements of the CS, coronary arteries and
the mitral valve with the surrounding tissue in different
planes and that precise preoperative planning could improve
device implantation and prevent potential complications.
The function mode of this device seems promising and
comprehensible. Especially this study shows significant
anatomic differences between normal and MVI, which might
be the basis for any interventional approaches through the
CS. In addition this study pronounces the importance for
precise preselection of patients and planning of the
procedure individually modified to the patient before any
manipulation of the CS.
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Appendix A. Conference discussion
Dr O. Alfieri (Milan Italy): This study reinforces the concept that
appropriate imaging techniques are absolutely necessary for percutaneous
valve intervention. Specifically, multi-slice CT is clearly providing an excellent
assessment of the anatomic details which are necessary for mitral annuloplasty
using coronary sinus devices. The idea of custom made devices is put forward
for optimization of the results, and this is certainly an interesting perspective,
although the practicality remains doubtful. Maybe you can comment a little bit
on that.
Considering the clinical material in this study, mostly patients with leaflet
prolapse, the coronary sinus annuloplasty is envisioned as a procedure to be
added, for instance, to the percutaneous edge-to-edge technique, not as anisolated procedure. And this is of interest because up to now the coronary sinus
annuloplasty has been only used in functional mitral regurgitation.
I have objections in regard to the study design. The anatomical variability
in individual patients is certainly more important than the variability induced
by the presence of mitral regurgitation. After all, every candidate to coronary
sinus annuloplasty has got mitral regurgitation. The control group is not
represented by normal hearts but by hearts with aortic valve disease. Actually
this didn’t turn out in your presentation but that fact in the manuscript is very
well described. The differences in the two groups are essentially limited to the
size of the coronary sinus, reflecting the pathophysiology in the two groups.
Having said that, I have only one question.
Considering the relationship between the coronary sinus and the
circumflex artery, and also taking into account other important anatomical
features like the distance of the coronary sinus from the mitral annulus, in how
many patients in your series could the coronary sinus annuloplasty have been
safely applicable?
Dr Plass: Of course, this is a little bit dangerous what I will say now, but I
estimate it is around not more than 60% at present, because different factors
play a role, for example the fact that the diameter in more than 80% of the
circumflex branch decrease if the run is under the coronary sinus. I mean, it is
not yet clear if there is now after an implantation of a device for sure also a
further compression of the circumflex branch which would cause a
hemodynamic situation. There are many discussions in past papers, but the
probability is, of course, higher.
And also the question of efficacy, I don’t know if the run of the coronary
sinus in the back wall of the atrium and not on the same level of the mitral
valve annulus decrease the efficacy. In addition there could be other changes
of the geometry of the mitral valve annulus, nobody knows exactly. It is only a
guess because of the data of this anatomical study, but I think for sure it is not
more than 60%.
Dr F. Mohr (Leipzig, Germany): Just briefly to update you on numbers, they
had been presented last week at the EAC. Fifty-five patients had that implant,
and obviously in patients who had a feasible anatomy. The effect of these
devices was rather poor; a median MR of 2.5 was reduced to 1.8. So I think this
has to be kept in mind over here. And also you have to say that the device you
showed is off the market right now because of technical problems. So I very
much appreciate the studies you do. There is also a similar study from Paris who
underlines the same situation as you, and I would rather think that the
likelihood that one of these devices would work from these studies is less than
60, maybe 20%, if at all.
Dr R. De Simone (Heidelberg, Germany): I really appreciated what you said
about the anatomical relationship between coronary sinus and mitral valve.
My question is: why should we surgeons help cardiologists in performing
these procedures, if we just consider that this field represents a domain of
interest for cardiologists. In addition, performing these complicated
procedures has a very high risk. We have just to consider following major
concerns. First, the coronary sinus is a very fragile structure; second, the
anatomical relationship to the mitral valve makes the feasibility questionable;
third, in case of failure or rupture of such a device, do you have an idea how to
rescue this device and how difficult is to repair the coronary sinus. And finally,
since this procedure will probably be done by the cardiologists, don’t you think
that the apical approach to the mitral valve may be the ideal field of interest
and further development for heart surgeons?
Dr Plass: I agree in all named facts of Dr de Simone. And also Professor
Mohr is right, probably it is only 20%. I only named 60%, if you note the
anatomical data, already then it is less than 60%. If you imply the functional
mode and the complete constellation, probably it is lower than 20%. And this
study should declare that the technique is interesting but otherwise it is not
yet the situation to be used in clinical routine. There are playing in so many
factors, although the approach, like also Dr de Simone mentioned, could
probably be in another direction and for the positioning helpful. This study
should pronounce that there should be a critical view to the different devices,
and also to pronounce as more you go for minimally invasive as more important
is preoperative planning and imaging by navigation intraoperatively. This
should be illustrated by this kind of study, the same is true for the study of the
anatomy for the valve-in-valve procedure presented by Dr Grunenfelder
before.
Dr De Simone: There are cardiologists who are already doing patients.
Dr Plass: I know this, yes.
Dr De Simone: This is an ethical problem, a major ethical problem.
